Results: The pharmacokinetics of intravenous fentanyl ... with a lag of approximately 5 minutes and a half-life of approximately 6.5 minutes. Interpatient absorption variability was approximately ...

Enhanced half-life of genetically engineered human IgG1 ... Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies. Methods Mol Biol 602:93-104. PMID: 20012394.

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

Study highlights the safety and early bactericidal activity of quabodepistat when combined with delamanid, bedaquiline, or ...

Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation ...

Furthermore, this call invites studies that elucidate the pharmacokinetic profiles of various therapeutic agents targeting redox signaling pathways in the context of inflammation-associated diseases.

Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...

AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

Janux Therapeutics' innovative cancer treatment shows promise in reducing side effects and improving patient outcomes, but ...

Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.

However, new research into COVID prophylaxis and therapeutics offers some hope that novel treatments may be on the horizon.